Not Tagged
gilead
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'thanks', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'leusm', 'mds', 'leukemia', 'gilead']
thanks for joining gilead at #asco23! research into the #cd47 pathway continues: could blocking cd47 have the potential to enhance antitumor immunity? , explore the case at #aml #mds #leusm #leukemia
Gilead Sciences is committed to researching innovative therapies for patients with MDS. 
© 2021 Gilead Sciences, Inc. All rights reserved. US-UNBP-0191 09/21